Once when the vaccine is a success.

i see merit in all the points mentioned by the writers, esp the fall in investments.

foreign and domestic, this has been going on for some years now.. plus continuous huge gomen spending w/o investment value.

but i disagree on the inflation.... i dun think deflation will happen here; inflation will continue except for big tickets - houses, cars, office rents.

the scenario painted doesn't bode well for bursa at all.... except gloves if demand stays.

the question always is... when it dips, will u buy?

hard to advice u.

if u see it going to 25 or higher, any dip is good opportunity to buy.

if u see it crashing to 10 like some people, never buy la...

What is PE of tesla? 374?

topglove is 98.24...

seems like only 3-4x more expensive

supermax already 151

all the excitement....!

but wait la... entitlement date is 3Q, long way off.

how many will buy now and hold till then, wait for ex-date to pass?
more interesting now is this afternoon, how far up these announcements will push TG, spmx.

TG 25m, Spmx 19 is a given... how much further?

vaccine not even here yet, glove business is more real if compared however insanely overpriced, look elsewhere. Play sentiment will get burn big one day.

no. i was just thinking...
that commentary was written after fri, cited bloomberg using a TG eps that gives a p/e ratio of 48.
it was then pointed out that bloomberg has since used an eps of 1.242 which will now give p/e of 20.
20 is low compared to the nos. quoted for supermax and harta.
my thought was bloomberg must have gotten fresh info for the 12m fwd earnings and started to use a new eps.
if that is the case, this may have an impact on their clients this week as it implies renewed bullishness.
as pointed out by boon, this is the game all analysts play... forecasting is at best mathematical statistics, not an exact science.
we shall see this morning is this observation is relevant or not.

note also while FY2021E is very rosy, FY2022E is not.
this is the same for several other forecasts that i have seen.
i wud take that to mean they see 2021 as the peak yr for gloves in terms of revenues and margins while some vaccine, new capacity or other development will curtail it by yr beginning 2022 - a reasonable underlying assumption, i suppose.

lastly, if such a forecast will come true, what might other development emerge for TG?
what is the chief and his lieutenants thinking now?
with a few billion rm in cash at hand by mid 2021, what might they want to do?
pay all out in dividend? invest all into new gloves capacity?
or buy out some competitor? buy out some related biz co., e.g. mask, PPE, pharma?
just something to think about...